Big Pharma's mass outsourcing led to SARS-CoV-2 injections—they sold all their drug development assets to pursue patents and power marketing
It's a long story, but I'll keep it short
What is outsourcing?
For those not fully sure what outsourcing means, this is a simplified version:
“Businesses may chose to get companies they do not own to carry out some of the activities they need to keep the business running and make a profit”.
This is classically known in the procurement world as the ‘make v buy’ decision.
Make = Your company develops (designs) and manufactures a product, component or raw material.
Buy = Another company develops (designs) and manufacturers a product, component or raw material.
It sounds simple, but it is crucially important to get the strategy right. Again, in simple terms, it means keeping the assets required to beat your competition in-house.
Once those assets and skills have been identified and secured, other activities can be bought-out (from outside the business). Even companies that appear to have outsourced a significant amount of activities off-shore, such as Dyson, keep their crown jewels of design and manufacturing know-how inside the company.